Evidence map›Paper›PMID 25713215›Full record

ArticleCirculation. Arrhythmia and electrophysiology2015

Quantification of the transmural dynamics of atrial fibrillation by simultaneous endocardial and epicardial optical mapping in an acute sheep model.

Sarah R Gutbrod, Richard Walton, Stephen Gilbert, Valentin Meillet, Pierre Jaïs, Mélèze Hocini, Michel Haïssaguerre, Rémi Dubois, Olivier Bernus, Igor R Efimov

Open access · greenAbstract read
In one paragraph

Article in Circulation. Arrhythmia and electrophysiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 42 citations in OpenAlex.

  1. Using computed tomography atrial myocardial thickness maps in cryoballoon pulmonary vein isolation: the UTMOST AF II randomized clinical trial.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2024
    Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Challenges Associated with Interpreting Mechanisms of AF.Arrhythmia & electrophysiology review · 2020
    Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Optical coherence tomography imaging of cardiac substrates.Quantitative imaging in medicine and surgery · 2019
    Review
  16. Determinants of new wavefront locations in cholinergic atrial fibrillation.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2018
    Article
  17. Article
  18. Article
  19. Article
  20. Mechanistic targets for the ablation of atrial fibrillation.Global cardiology science & practice · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Sarah R GutbrodFrom the Department of Biomedical Engineering, Washington University in Saint Louis, MO (S.R.G., I.R.E.); L'Institut de Rythmologie et Modélisation Cardiaque LIRYC, Université de Bordeaux, France (S.R.G., R.W., S.G., V.M., P.J., M.H., M.H., R.D., O.B., I.R.E.); Inserm, Centre de Recherche Cardio-Thoracique de Bordeaux U1045, Bordeaux, France (R.W., V.M., P.J., M.H., M.H., R.D., O.B.); Université de Bordeaux, Centre de Recherche Cardio-Thoracique de Bordeaux U1045, Bordeaux, France (R.W., V.M., P.J., M.H., M.H., R.D., O.B.); CHU de Bordeaux, Hôpital du Haut Lévêque, Pessac, France (V.M., P.J., M.H., M.H.); and Max Delbrück Center for Molecular Medicine, Berlin, Germany (S.G.).
Richard WaltonFrom the Department of Biomedical Engineering, Washington University in Saint Louis, MO (S.R.G., I.R.E.); L'Institut de Rythmologie et Modélisation Cardiaque LIRYC, Université de Bordeaux, France (S.R.G., R.W., S.G., V.M., P.J., M.H., M.H., R.D., O.B., I.R.E.); Inserm, Centre de Recherche Cardio-Thoracique de Bordeaux U1045, Bordeaux, France (R.W., V.M., P.J., M.H., M.H., R.D., O.B.); Université de Bordeaux, Centre de Recherche Cardio-Thoracique de Bordeaux U1045, Bordeaux, France (R.W., V.M., P.J., M.H., M.H., R.D., O.B.); CHU de Bordeaux, Hôpital du Haut Lévêque, Pessac, France (V.M., P.J., M.H., M.H.); and Max Delbrück Center for Molecular Medicine, Berlin, Germany (S.G.).
Stephen GilbertFrom the Department of Biomedical Engineering, Washington University in Saint Louis, MO (S.R.G., I.R.E.); L'Institut de Rythmologie et Modélisation Cardiaque LIRYC, Université de Bordeaux, France (S.R.G., R.W., S.G., V.M., P.J., M.H., M.H., R.D., O.B., I.R.E.); Inserm, Centre de Recherche Cardio-Thoracique de Bordeaux U1045, Bordeaux, France (R.W., V.M., P.J., M.H., M.H., R.D., O.B.); Université de Bordeaux, Centre de Recherche Cardio-Thoracique de Bordeaux U1045, Bordeaux, France (R.W., V.M., P.J., M.H., M.H., R.D., O.B.); CHU de Bordeaux, Hôpital du Haut Lévêque, Pessac, France (V.M., P.J., M.H., M.H.); and Max Delbrück Center for Molecular Medicine, Berlin, Germany (S.G.).
Valentin MeilletFrom the Department of Biomedical Engineering, Washington University in Saint Louis, MO (S.R.G., I.R.E.); L'Institut de Rythmologie et Modélisation Cardiaque LIRYC, Université de Bordeaux, France (S.R.G., R.W., S.G., V.M., P.J., M.H., M.H., R.D., O.B., I.R.E.); Inserm, Centre de Recherche Cardio-Thoracique de Bordeaux U1045, Bordeaux, France (R.W., V.M., P.J., M.H., M.H., R.D., O.B.); Université de Bordeaux, Centre de Recherche Cardio-Thoracique de Bordeaux U1045, Bordeaux, France (R.W., V.M., P.J., M.H., M.H., R.D., O.B.); CHU de Bordeaux, Hôpital du Haut Lévêque, Pessac, France (V.M., P.J., M.H., M.H.); and Max Delbrück Center for Molecular Medicine, Berlin, Germany (S.G.).
Pierre JaïsFrom the Department of Biomedical Engineering, Washington University in Saint Louis, MO (S.R.G., I.R.E.); L'Institut de Rythmologie et Modélisation Cardiaque LIRYC, Université de Bordeaux, France (S.R.G., R.W., S.G., V.M., P.J., M.H., M.H., R.D., O.B., I.R.E.); Inserm, Centre de Recherche Cardio-Thoracique de Bordeaux U1045, Bordeaux, France (R.W., V.M., P.J., M.H., M.H., R.D., O.B.); Université de Bordeaux, Centre de Recherche Cardio-Thoracique de Bordeaux U1045, Bordeaux, France (R.W., V.M., P.J., M.H., M.H., R.D., O.B.); CHU de Bordeaux, Hôpital du Haut Lévêque, Pessac, France (V.M., P.J., M.H., M.H.); and Max Delbrück Center for Molecular Medicine, Berlin, Germany (S.G.).
Mélèze HociniFrom the Department of Biomedical Engineering, Washington University in Saint Louis, MO (S.R.G., I.R.E.); L'Institut de Rythmologie et Modélisation Cardiaque LIRYC, Université de Bordeaux, France (S.R.G., R.W., S.G., V.M., P.J., M.H., M.H., R.D., O.B., I.R.E.); Inserm, Centre de Recherche Cardio-Thoracique de Bordeaux U1045, Bordeaux, France (R.W., V.M., P.J., M.H., M.H., R.D., O.B.); Université de Bordeaux, Centre de Recherche Cardio-Thoracique de Bordeaux U1045, Bordeaux, France (R.W., V.M., P.J., M.H., M.H., R.D., O.B.); CHU de Bordeaux, Hôpital du Haut Lévêque, Pessac, France (V.M., P.J., M.H., M.H.); and Max Delbrück Center for Molecular Medicine, Berlin, Germany (S.G.).
Michel HaïssaguerreFrom the Department of Biomedical Engineering, Washington University in Saint Louis, MO (S.R.G., I.R.E.); L'Institut de Rythmologie et Modélisation Cardiaque LIRYC, Université de Bordeaux, France (S.R.G., R.W., S.G., V.M., P.J., M.H., M.H., R.D., O.B., I.R.E.); Inserm, Centre de Recherche Cardio-Thoracique de Bordeaux U1045, Bordeaux, France (R.W., V.M., P.J., M.H., M.H., R.D., O.B.); Université de Bordeaux, Centre de Recherche Cardio-Thoracique de Bordeaux U1045, Bordeaux, France (R.W., V.M., P.J., M.H., M.H., R.D., O.B.); CHU de Bordeaux, Hôpital du Haut Lévêque, Pessac, France (V.M., P.J., M.H., M.H.); and Max Delbrück Center for Molecular Medicine, Berlin, Germany (S.G.).
Rémi DuboisFrom the Department of Biomedical Engineering, Washington University in Saint Louis, MO (S.R.G., I.R.E.); L'Institut de Rythmologie et Modélisation Cardiaque LIRYC, Université de Bordeaux, France (S.R.G., R.W., S.G., V.M., P.J., M.H., M.H., R.D., O.B., I.R.E.); Inserm, Centre de Recherche Cardio-Thoracique de Bordeaux U1045, Bordeaux, France (R.W., V.M., P.J., M.H., M.H., R.D., O.B.); Université de Bordeaux, Centre de Recherche Cardio-Thoracique de Bordeaux U1045, Bordeaux, France (R.W., V.M., P.J., M.H., M.H., R.D., O.B.); CHU de Bordeaux, Hôpital du Haut Lévêque, Pessac, France (V.M., P.J., M.H., M.H.); and Max Delbrück Center for Molecular Medicine, Berlin, Germany (S.G.).
Olivier BernusFrom the Department of Biomedical Engineering, Washington University in Saint Louis, MO (S.R.G., I.R.E.); L'Institut de Rythmologie et Modélisation Cardiaque LIRYC, Université de Bordeaux, France (S.R.G., R.W., S.G., V.M., P.J., M.H., M.H., R.D., O.B., I.R.E.); Inserm, Centre de Recherche Cardio-Thoracique de Bordeaux U1045, Bordeaux, France (R.W., V.M., P.J., M.H., M.H., R.D., O.B.); Université de Bordeaux, Centre de Recherche Cardio-Thoracique de Bordeaux U1045, Bordeaux, France (R.W., V.M., P.J., M.H., M.H., R.D., O.B.); CHU de Bordeaux, Hôpital du Haut Lévêque, Pessac, France (V.M., P.J., M.H., M.H.); and Max Delbrück Center for Molecular Medicine, Berlin, Germany (S.G.).
Igor R EfimovFrom the Department of Biomedical Engineering, Washington University in Saint Louis, MO (S.R.G., I.R.E.); L'Institut de Rythmologie et Modélisation Cardiaque LIRYC, Université de Bordeaux, France (S.R.G., R.W., S.G., V.M., P.J., M.H., M.H., R.D., O.B., I.R.E.); Inserm, Centre de Recherche Cardio-Thoracique de Bordeaux U1045, Bordeaux, France (R.W., V.M., P.J., M.H., M.H., R.D., O.B.); Université de Bordeaux, Centre de Recherche Cardio-Thoracique de Bordeaux U1045, Bordeaux, France (R.W., V.M., P.J., M.H., M.H., R.D., O.B.); CHU de Bordeaux, Hôpital du Haut Lévêque, Pessac, France (V.M., P.J., M.H., M.H.); and Max Delbrück Center for Molecular Medicine, Berlin, Germany (S.G.). efimov@gwu.edu.
Washington University in St. Louis · US

Funding

Low Energy DefibrillationR01HL115415 · NHLBI · WASHINGTON UNIVERSITY · PI EFIMOV, IGOR R · 2013 to 2016
$2.1M
OPTO-ELECTRIC MAPPING OF ACTION POTENTIALSR21HL112278 · NHLBI · WASHINGTON UNIVERSITY · PI EFIMOV, IGOR R · 2012 to 2013
$428k
Low energy ventricular defibrillatorR41HL114329 · NHLBI · CARDIALEN, INC. · PI EFIMOV, IGOR R, SHA, QUN · 2012 to 2012
$251k
NHLBI NIH HHS R01 HL115415NHLBI NIH HHS R21 HL112278NHLBI NIH HHS R41 HL114329NHLBI NIH HHS R43 HL114329
6 · The paper itself

Abstract

backgroundTherapy strategies for atrial fibrillation based on electric characterization are becoming viable personalized medicine approaches to treat a notoriously difficult disease. In light of these approaches that rely on high-density surface mapping, this study aims to evaluate the presence of 3-dimensional electric substrate variations within the transmural wall during acute episodes of atrial fibrillation. METHODS AND

resultsOptical signals were simultaneously acquired from the epicardial and endocardial tissue during acute fibrillation in ovine isolated left atria. Dominant frequency, regularity index, propagation angles, and phase dynamics were assessed and correlated across imaging planes to gauge the synchrony of the activation patterns compared with paced rhythms. Static frequency parameters were well correlated spatially between the endocardium and the epicardium (dominant frequency, 0.79 ± 0.06 and regularity index, 0.93 ± 0.009). However, dynamic tracking of propagation vectors and phase singularity trajectories revealed discordant activity across the transmural wall. The absolute value of the difference in the number, spatial stability, and temporal stability of phase singularities between the epicardial and the endocardial planes was significantly >0 with a median difference of 1.0, 9.27%, and 19.75%, respectively. The number of wavefronts with respect to time was significantly less correlated and the difference in propagation angle was significantly larger in fibrillation compared with paced rhythms.

conclusionsAtrial fibrillation substrates are dynamic 3-dimensional structures with a range of discordance between the epicardial and the endocardial tissue. The results of this study suggest that transmural propagation may play a role in atrial fibrillation maintenance mechanisms.

Indexed as

Epicardial MappingAction PotentialsAcute DiseaseAnimalsAtrial FibrillationAtrial Function, LeftDisease Models, AnimalEndocardiumFeasibility StudiesHeart AtriaPericardiumPredictive Value of TestsSheepSignal Processing, Computer-AssistedTime Factorsatrial fibrillationelectrophysiologyreentryrotor

Identifiers

PMID25713215
PMCPMC4668124
OpenAlexW2115726798

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.